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STUDY PROTOCOL Open Access
Core outcomes in periodontal trials: study
protocol for core outcome set
development
Thomas J. Lamont1*, Jan E. Clarkson1, David N. J. Ricketts1, Peter A. Heasman2 and Craig R. Ramsay3
Abstract
Background: There are a large number of clinical outcome measures used to assess the effectiveness of prevention
and management strategies of periodontal diseases. This heterogeneity causes difficulties when trying to synthesise
data for systematic reviews or clinical guidelines, reducing their impact. Core outcome sets are an agreed, standardised
list of outcomes that should be measured and reported in all trials in specific clinical areas. We aim to develop a core
outcome set for effectiveness trials investigating the prevention and management of periodontal disease in primary
or secondary care.
Methods: To identify existing outcomes we screened the Cochrane systematic reviews and their included studies
on the prevention and management of periodontal diseases. The core outcome set will be defined by consensus
of key stakeholders using an online e-Delphi process and face-to-face meeting. Key stakeholders involved in the
development will include: patients, dentists, hygienists/therapists, specialists, clinical researchers and policy-makers.
Stakeholders will be asked to prioritise outcomes and feedback will be provided in the next round(s). Stakeholders
will have an opportunity to add outcomes found in the Cochrane review screening process at the end of the first
round. If consensus is not reached after the second round we will provide feedback prior to a third round.
Remaining outcomes will be discussed at a face-to-face meeting and agreement will be measured via defined
consensus rules of outcome inclusion.
Discussion: The inclusive consensus process should provide a core outcome set that is relevant to all key
stakeholders. We will actively disseminate our findings to help improve clinical trials, systematic reviews and
clinical guidelines with the ultimate aim of improving the prevention and management of periodontal diseases.
Trial registration: COMET (http://www.comet-initiative.org/studies/details/265?result=true). Registered on August 2012.
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Background
Periodontal (gum) disease and caries (tooth decay) are
the world’s most prevalent noncommunicable diseases.
These diseases are largely preventable, yet they remain
the major cause of poor oral health worldwide affecting
an estimated four billion individuals in 2010 [1–3].
Periodontal disease affects tissues surrounding and
supporting the teeth and is classified into two broad
categories: gingivitis and periodontitis. Gingivitis is a
reversible condition characterised by inflammation and
bleeding of the gingiva. Periodontitis is the irreversible
destruction and loss of the supporting periodontal
structures (periodontal ligament, cementum and alveolar
bone). The result is often gingival recession, sensitivity of
the exposed root surface, root caries (decay), mobility and
drifting of teeth and, ultimately, tooth loss. Periodontal
disease is the primary cause of tooth loss in older adults
[4, 5]. Untreated caries in permanent teeth is ranked as
the most prevalent global condition with severe peri-
odontal disease ranked sixth [6].
Periodontal disease shares common risk factors with
other chronic diseases and conditions, such as obesity,* Correspondence: t.lamont@dundee.ac.uk
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heart disease, stroke, cancer, chronic obstructive pul-
monary disease and diabetes. These include age, diet,
physical inactivity, stress, immune system susceptibility,
smoking and alcohol use. It is also recognised that
there can be a bidirectional relationship between peri-
odontal disease and other diseases. For example, recent
research shows that chronic periodontitis has an ad-
verse effect on the control of blood sugar, and the inci-
dence of diabetic complications. Periodontal disease
has also been associated with rheumatoid arthritis, cor-
onary heart disease and adverse pregnancy outcomes
[7–10]. Whilst causation has not been proven, the pre-
vention and management of periodontal disease for
these individuals is considered important for general
wellbeing and quality of life.
Recent clinical guidance and systematic reviews have
highlighted the lack of high-quality evidence regarding
the prevention and management of periodontal disease
[11–13]. Part of the reason for this is the large number
of outcomes and clinical indices that are measured
within the trials comparing the effectiveness of the
management options. This heterogeneity of outcome
measures has created difficulties when trying to com-
pare or combine different study results leading to the
confusion of patients and clinicians when considering
the best treatment options. There is currently no con-
sensus as to which outcomes should be measured when
investigating interventions for periodontal disease.
The COMET (Core Outcome Measures in Effective-
ness Trials) initiative (http://www.comet-initiative.org)
brings together researchers interested in the develop-
ment, application and promotion of core outcome sets
(COS), that are defined as an agreed, standardised
collection of outcomes which should be measured and
reported in all trials for a specific clinical area. They
represent the minimum that should be measured and
reported upon in all trials, and are also suitable for
other types of research and audit.
The COMET initiative maintains a database of com-
pleted and ongoing COS protocols and documents that
are freely available to the public. This project has been
registered on the COMET database.
Developing a COS for periodontal disease will encour-
age clinical researchers/trialists to use outcomes chosen
by consensus that are relevant to patients and clinicians
and help data synthesis and dissemination in the future.
Objectives and scope
We will lead the development of a COS for the man-
agement of periodontal disease. The outcome set will
be applicable to effectiveness trials investigating the
prevention and management of periodontal disease in
primary or secondary care. It will not be limited by
health status, age or the geographical location of trials.
The core set will be developed for the prevention and
management of periodontal diseases due to the overlap of
their traditional management strategies, e.g. oral-hygiene
aids and interventions are important aspects of both.
Methods
Identifying existing knowledge
To find potentially relevant outcome domains in the
current academic literature we searched the Cochrane
database of systematic reviews for relevant published
reviews and protocols investigating the prevention and
treatment of periodontal disease. The search was con-
ducted up to July 2016. From the reviews and protocols
that met our inclusion criteria we recorded the type of
intervention(s), outcome measures (clinical, patient and
economic) and duration of follow-up that the authors
stated that they would investigate. We subsequently
extracted data from all the trials within the included
reviews and recorded additional outcome measures and
indices reported by these trials. One investigator (TL) in-
dependently extracted the data and the results were
reviewed by a second investigator (JC). Results were tab-
ulated using Microsoft Office. A list of unique outcome
measures reported was compiled.
Consensus process
The COS will be developed by a consensus process in-
volving key stakeholders, namely patients and dental
professionals as well as clinical researchers, health econ-
omists, statisticians, policy-makers and industry repre-
sentatives with experience in dental research. Patient
participants will be recruited from across Scotland using
the SHARE network and dental professionals and re-
searchers will be contacted via professional bodies. To
increase COS uptake, we will engage with the Cochrane
Oral Health Group, clinical guideline developers, re-
search funders, journal editors, regulators, such as re-
search ethics committees, and trial registries. We will
attempt to ensure adequate representation from each of
the stakeholder groups to improve the acceptance and
implementation of the COS. We will attempt to gain
consensus via an online e-Delphi process which was
chosen as the most efficient and pragmatic method of
including the key stakeholders from different settings,
backgrounds and geographical locations.
Stakeholders will be sent an invitation (plain language
version sent where appropriate) with the background of
the COS development process provided with additional
information regarding the practicalities of the consensus
process. Participants will be asked to opt in by replying
to the invitation. To minimise attrition, only those
stakeholders confirming that they would like to be in-
volved in the process will be invited to complete the
first round.
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Outcomes will be presented in lay terms with the
dental terms in brackets to ensure that all participants
understand the terminology. The outcomes will be pre-
sented in alphabetical order and the participants will be
asked to score each outcome from the combined long
list using the scale proposed by the GRADE group
(http://www.gradeworkinggroup.org), in which 1 to 3 sig-
nifies an outcome of limited importance, 4 to 6 important
but not critical, and 7 to 9 critical.
Reminders will be sent before the end of each round
to those participants who completed the previous round
but have not yet responded by 2 weeks after invitation.
At the end of the first round participants will be given
the opportunity to suggest any outcome measures that
they would consider relevant but missing from the list of
outcomes. They will be informed that a minimum of
two participants will have to propose an outcome for it
to be included in the next round of the process.
At the end of each round, responses will be sum-
marised into two groups: (1) patient participants and (2)
all other participants. To be retained into the second
round of the e-Delphi process, outcomes will require
50% or more of the respondents in either stakeholder
group score it 7 to 9 and fewer than 15% score it as 1 to 3.
Participants who completed round 1 will be invited to
complete round 2. Participants will be reminded of their
own scores from the previous round for each outcome.
They will also be informed of the percentage of individuals
from each stakeholder group who rated each of scores 1
through to 9. Participants will be invited to rescore each
of the outcomes remaining in the e-Delphi process. They
will be advised that they do not need to change their score
if they do not want to.
Although we envisage that three rounds may be neces-
sary, we will stop the process following the second round
if we reach consensus of 70% or more of the respondents
in both groups scoring the remaining outcome’s inclusion
as critical (7 to 9) and fewer than 15% score the outcome
as not important (1 to 3). If these consensus criteria are
not achieved for all outcomes following the second round,
the e-Delphi process will be re-run for a third time. Feed-
back will again be provided to all participants, with indi-
vidual scores and the percentage of individuals from each
stakeholder group that rated each of scores 1 through to
9. Prior to the end of round 3, reminders will be sent to
those participants who completed round 2 but have not
completed round 2 after 2 weeks.
The remaining outcomes will be taken forward to a
face-to-face meeting for discussion with key stakeholders.
Face-to-face meeting
At the end of the second round of the e-Delphi process
we will ask each participant if they would be willing to
take part in a face-to-face meeting to discuss the
findings of the process following completion of the e-
Delphi. We will reconfirm their willingness if a third
round is required. This will be a nominal group meeting
held in Dundee, involving 11 participants with represen-
tation from each stakeholder groups. Participants will be
chosen at random from those expressing willingness to
attend. The meeting will be co-facilitated by the lead re-
searcher who is a clinician, as well as an independent
methodologist who has experience with group consensus
meetings. A detailed protocol will be finalised after the
last e-Delphi round.
Dissemination
To help increase the uptake of the COS we will engage
with relevant groups such as the Cochrane Oral Health
Group, the British Society of Periodontology, the European
Federation of Periodontology, the American Academy of
Periodontology, the International Association for Dental
Research Periodontal Research Network, guideline devel-
opment groups including the National Institute for Clinical
Excellence, the Scottish Intercollegiate Guideline Network
and the Scottish Dental Clinical Effectiveness Programme,
journal editors, trial registries and major funding bodies
such as the UK National Institute for Health Research
(NIHR) Health Technology Assessment (HTA).
Discussion
Increasingly, there is a greater understanding and emphasis
being placed on research being accessible and relevant to
all key stakeholders [14]. Historically, the outcome mea-
sures used in clinical trials have been chosen largely by the
trialists and academics. A number of recent Cochrane
systematic reviews have highlighted the need to include pa-
tient, clinician and economic-orientated outcomes in future
studies [15, 16]. This COS development process and dis-
semination will start to raise awareness of outcome meas-
ure selection and the impact that the selection decisions
can have on the synthesis and translation of the evidence
base. The COMET initiative is developing COSs in a wide
variety of health care areas and similar projects have com-
menced in other areas of dentistry, namely cariology [17].
Trial status
The review stage of identifying existing outcomes is
complete and the e-Delphi process is currently being
planned.
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